WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. (Q37371387)
Jump to navigation
Jump to search
scientific article published on 21 May 2009
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. |
scientific article published on 21 May 2009 |
|
Statements
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease (English)
David A Price
Alex A Martinez
Alexandre Seillier
Wouter Koek
Yolanda Acosta
Randy Strong
Beat Lutz
James L Roberts
Andrea Giuffrida
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference